Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial

DSpace Repository

Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial

Author: Weidner, Norbert; Abel, Rainer; Maier, Doris; Roehl, Klaus; Roehrich, Frank; Baumberger, Michael; Hund-Georgiadis, Margret; Saur, Marion; Benito, Jesus; Rehahn, Kerstin; Aach, Mirko; Badke, Andreas; Kriz, Jiri; Barkovits, Katalin; Killeen, Tim; Farner, Lynn; Seif, Maryam; Hubli, Michele; Marcus, Katrin; Maurer, Michael A.; Robert, Berenice; Rupp, Ruediger; Scheuren, Paulina S.; Schubert, Martin; Schuld, Christian; Sina, Christina; Steiner, Bettina; Weis, Tanja; Hug, Andreas; Bolliger, Marc; Weiskopf, Nikolaus; Freund, Patrick; Hothorn, Torsten; Schwab, Martin E.; Curt, Armin
Tübinger Autor(en):
Badke, Andreas
Published in: Lancet Neurology (2025), Bd. 24, H. 1, S. 42-53
Verlagsangabe: New York : Elsevier Science Inc
Language: English
Full text: http://dx.doi.org/10.1016/S1474-4422(24)00447-2
ISSN: 1474-4422
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)